Table 2.
The expression level of SEMG2 is negatively associated with survival rate of cancer patients.
| Dataset (GEO ID) | Type of cancer | Effect on survival | P-value |
|---|---|---|---|
| GSE7390 | Breast carcinoma | Positive | 0.0355 |
| TCGA_COAD | Colon adenocarcinoma | Negative | 0.000515 |
| TCGA_KIRP | Renal cell papillary carcinoma | Negative | 0.00158 |
| GSE10846 | Large B-cell lymphoma | Negative | 0.00337 |
| TCGA_PAAD | Pancreatic adenocarcinoma | Negative | 0.00626 |
| TCGA_SARC | Sarcoma | Negative | 0.00707 |
| TCGA_UCS | Uterus carcinoma | Negative | 0.0292 |
| TCGA_BRCA | Invasive breast carcinoma | Negative | 0.0183 |